Clinical Trials
Clinical Trials
We perform clinical trials to improve the health of children in Rochester, the nation, and the world. Through our achievements and focus on surfactant in premature infants, HIB Vaccine for infants and children, and human papillomavirus vaccine for adolescents, we have significantly decreased disease and improved the health of children internationally. Uniquely, we focus on the intersections among basic scientists, translational scientists, and clinical researchers involved in our studies. This infrastructure affords the opportunity for research to go from “Bench to Bedside.”
The Value and Cost of Clinical Research Studies
The Department of Pediatrics has over 360 active studies and represents the largest portfolio of studies at the University of Rochester Medical Center. Funding for research emanates from a wide variety of sources such as the federal government, industry and pharmaceutical companies, sponsors, grants, foundations, and departmental research funded by the Department of Pediatrics. Studies encompass a broad range of research endeavors, including clinical trials, behavioral health, health services research, and observation and outcomes research.
Resources
- Clinical Research Center (CRC) (URMC)
- Clinical Trials Coordination Center (CTCC) The CTCC works in collaboration with the Department of Biostatistics and Computational Biology at the University of Rochester to provide a complete suite of clinical trials services.
- Research Subject Review Board (RSRB) (UR)
An Inspiring Story of Hope Through Clinical Trials
When 16-year-old Mary Sarah’s heart stopped, she needed more than a miracle—she needed innovation. Her family said yes to a national clinical trial that uses the Arctic Sun system, which quickly lowers body temperature to minimize further brain injury.
